Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6505)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Dec 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qi XS, Ren WR, Fan DM, Han GH. Selection of treatment modalities for Budd-Chiari Syndrome in China: A preliminary survey of published literature. World J Gastroenterol 2014; 20(30): 10628-10636 [PMID: 25132785 DOI: 10.3748/wjg.v20.i30.10628] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10628.htm |
| Number | Citing Articles |
| 1 |
Zhong-Ke Chen, Jing Fan, Chi Cao, Yu Li. Endovascular treatment for hepatic vein-type Budd–Chiari syndrome: effectiveness and long-term outcome. La radiologia medica 2018; 123(10): 799 doi: 10.1007/s11547-018-0907-2
|
| 2 |
Dominique-Charles Valla. Budd–Chiari syndrome/hepatic venous outflow tract obstruction. Hepatology International 2018; 12(S1): 168 doi: 10.1007/s12072-017-9810-5
|
| 3 |
Xingshun Qi, Weirong Ren, Yongji Wang, Xiaozhong Guo, Daiming Fan. Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies. Expert Review of Gastroenterology & Hepatology 2015; 9(6): 865 doi: 10.1586/17474124.2015.1024224
|
| 4 |
Dehan Liu, Qianqian Ren, Tianhe Ye, Chuansheng Zheng, Yangbo Su, Xiangwen Xia. Evaluation of dangerous collateral vessels and thrombus in Budd-Chiari syndrome patients with inferior vena cava obstruction. Abdominal Radiology 2022; 47(2): 869 doi: 10.1007/s00261-021-03354-8
|
| 5 |
X. Qi, G. Han, X. Guo, V. De Stefano, K. Xu, Z. Lu, H. Xu, A. Mancuso, W. Zhang, X. Han, D. C. Valla, D. Fan. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Alimentary Pharmacology & Therapeutics 2016; 44(11-12): 1152 doi: 10.1111/apt.13815
|
| 6 |
De‑Lei Cheng, Nan Zhu, Cheng‑Li Li, Wei‑Fu Lv, Wei‑Wei Fang, Ya Liu, Chuan‑Ting Li. Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd‑Chiari syndrome in patients and a rat model. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6835
|
| 7 |
Pengxu Ding. Response to “Re: Treatment of Budd–Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?”. European Journal of Vascular and Endovascular Surgery 2018; 56(1): 145 doi: 10.1016/j.ejvs.2018.04.002
|
| 8 |
Xiao Guo, Zhongkai Wang, Xu Geng, Yanan Shang, Yunlong Zhao, Maoheng Zu, Hao Xu. The change in the liver volume after direct intrahepatic portocaval shunt in patients with Budd-Chiari syndrome with diffuse hepatic vein occlusion. Abdominal Radiology 2022; 48(1): 291 doi: 10.1007/s00261-022-03683-2
|
| 9 |
Peng-Xu Ding, Tao Zhou, Xin-Wei Han, Hai-Tao Ma, Chao Liu, Jia-Yin Ding, Edward Wolfgang Lee. Inferior Vena Cava Rupture Caused by Perforation Route through a Collateral Vein during Endovascular Treatment of Budd-Chiari Syndrome: Case Report. Annals of Vascular Surgery 2020; 67: 564.e5 doi: 10.1016/j.avsg.2020.02.030
|
| 10 |
Wei Zhang, Yu-Long Tian, Qiao-Zheng Wang, Xiao-Wei Chen, Qi-Yang Li, Jin-Hang Han, Xu-Dong Chen, Ke Xu. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World Journal of Clinical Cases 2020; 8(14): 2930-2941 doi: 10.12998/wjcc.v8.i14.2930
|
| 11 |
César Jiménez Jiménez, Leonardo Randial Tagliapetra , Iván Silva, Fabián Alférez. Tratamiento endovascular del síndrome de Budd-Chiari, a propósito de un caso. Revista Colombiana de Cirugía 2019; 34(4): 386 doi: 10.30944/20117582.518
|
| 12 |
Peijin Zhang, Yanyan Zhang, Jing Zhang, Hui Wang, He Ma, Wei Wang, Xiuyin Gao, Hao Xu, Zhaojun Lu. Association between JAK2 rs4495487 Polymorphism and Risk of Budd-Chiari Syndrome in China. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/807865
|
| 13 |
Pengxu Ding, Wen Zhou, Jiayin Ding, Shaofeng Shui, Luo Xu, Edward Wolfgang Lee. Fracture of inferior vena cava stent after endovascular treatment for Budd-Chiari syndrome: A case series and literature review. Journal of Interventional Medicine 2023; 6(2): 99 doi: 10.1016/j.jimed.2023.04.004
|
| 14 |
De‑Lei Cheng, Nan Zhu, Hao Xu, Cheng‑Li Li, Wei‑Fu Lv, Wei‑Wei Fang, Chuan‑Ting Li. Outcomes of endovascular interventional therapy for primary Budd‑Chiari syndrome caused by hepatic venous obstruction. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6708
|
| 15 |
Peijin Zhang, He Ma, QiFen Min, Maoheng Zu, Zhaojun Lu. CALR mutations in Chinese Budd–Chiari syndrome patients. European Journal of Gastroenterology & Hepatology 2016; 28(3): 361 doi: 10.1097/MEG.0000000000000526
|
| 16 |
|
| 17 |
Qiuhe Wang, Guohong Han. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdominal Radiology 2018; 43(8): 1908 doi: 10.1007/s00261-017-1341-y
|
| 18 |
Xingshun Qi, Xiaozhong Guo, Daiming Fan. Difference in Budd‐Chiari syndrome between the west and china. Hepatology 2015; 62(2): 656 doi: 10.1002/hep.27628
|
| 19 |
Faisal Khan, Homoyon Mehrzad, Dhiraj Tripathi. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd–Chiari syndrome: A UK hepatologist's perspective. Journal of Translational Internal Medicine 2018; 6(3): 97 doi: 10.2478/jtim-2018-0022
|
| 20 |
Wei Zhang, Qiao-Zheng Wang, Xiao-Wei Chen, Hong-Shan Zhong, Xi-Tong Zhang, Xu-Dong Chen, Ke Xu. Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center. World Journal of Gastroenterology 2018; 24(10): 1134-1143 doi: 10.3748/wjg.v24.i10.1134
|
| 21 |
Chinmay Bhimaji Kulkarni, Srikanth Moorthy, Sreekumar Karumathil Pullara, Nirmal Kumar Prabhu, Ramiah Rajesh Kannan, Puthukudiyil Kader Nazar. Budd-Chiari syndrome managed with percutaneous recanalization: Long-term outcome and comparison with medical therapy. International Journal of Gastrointestinal Intervention 2019; 8(2): 74 doi: 10.18528/ijgii180001
|
| 22 |
Mark R. Pedersen, Peter Molloy, David Wood, Anil Seetharam. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome. Annals of Hepatology 2016; 15(1): 127 doi: 10.5604/16652681.1184288
|
| 23 |
Faisal Khan, Matthew J. Armstrong, Homoyon Mehrzad, Frederick Chen, Desley Neil, Rachel Brown, Owen Cain, Dhiraj Tripathi. Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome. Alimentary Pharmacology & Therapeutics 2019; 49(7): 840 doi: 10.1111/apt.15149
|
| 24 |
Peng‐Xu Ding, Xin‐Wei Han, Chao Liu, Yan Zhang, An‐Ling Cheng, Yan Wu, Xiao‐Xue Liang, Xue‐Mei Gao, Edward Wolfgang Lee. Long‐term outcomes of individualized treatment strategy in treatment of type I Budd‐Chiari syndrome in 456 patients. Liver International 2019; 39(8): 1577 doi: 10.1111/liv.14114
|
| 25 |
Chaowen Yu, Yong Gao, Zhonglin Nie, Tao Song, Shiyuan Chen, Ran Lu, Wenbo Tang. Effectiveness and Postoperative Prognosis of Using Preopening and Staged Percutaneous Transluminal Angioplasty of the Inferior Vena Cava in Treating Budd-Chiari Syndrome Accompanied with Inferior Vena Cava Thrombosis. Annals of Vascular Surgery 2019; 60: 52 doi: 10.1016/j.avsg.2019.03.037
|